Siddhartha Sen, MD, PhD

Assistant Professor, Department of Laboratory Medicine and Pathology

Siddhartha Sen

Contact Info

Office Phone 612-273-7552

Mailing Address:
MMC 609 Mayo
420 Delaware
Minneapolis, MN 55455

MD, University of Pune, India, 2001

Residency in Anatomic and Clinical Pathology, Duke University, 2020

Clinical Fellow, Molecular Genetic Pathology, Baylor College of Medicine, 2021

PhD, Biochemistry and Molecular Biology, LSU Health Sciences Center, 2006


Dr. Sen is a molecular pathologist with years of experience in translating research into novel therapies that can be quickly advanced from the bench to the clinic. The primary focus of his research has been in T-cell based immunotherapy to target malignant melanoma and in the development of novel therapies targeting leukemic stem cells (LSCs) in acute myelogenous leukemia (AML). His specialties include

Cancer immunology and immunotherapy

Oncology/cancer stem cell biology and signaling pathways

In vivo pharmacology studies: Mouse models of leukemia and melanoma

High throughput screening (HTS)

Multi-parameter flow cytometry

Confocal microscopy


Molecular diagnostics



Shuang Ma; Siddhartha Sen; Rachel Jug; Xuefeng Zhang; Wan-Lin Zhang; Shuai Shen; Cheng-Qian Yu; Hong-Tao Xu; Lian-He Yang; Endi Wang. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: Report of the first case and literature review. Medicine (Baltimore). 2018 Sep; 97(38): e12482.

Amanda Contreras; Megan V Beems; Andrew J Tatar; Siddhartha Sen; Prakrithi Srinand; Marulasiddappa Suresh; Tahra K Luther; Clifford S Cho. Co-transfer of tumor-specific effector and memory CD8+ T cells enhances the efficacy of adoptive melanoma immunotherapy in a mouse model. Journal for Immunotherapy of Cancer. 2018 May 29;6(1):4